|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
None
|
Compound treatment |
|
|
Homo sapiens
|
Organism |
|
|
Cerebellum
|
Organism part |
|
|
Epithelial cell
|
Cell type |
|
|
Cystic change
|
Histology |
|
|
FLAP
|
Compound treatment |
|
|
Glioblastoma
|
Disease state |
|
|
HNRPA2B
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Skin
|
Organism part |
|
|
MK886
|
Compound treatment |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Macaca mulatta
|
Organism |
|
|
Skeletal muscle
|
Organism part |
|
|
Fibroblast
|
Cell type |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
HeLa
|
Cell line |
|
|
A549
|
Cell line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
HL-60
|
Cell line |
|
|
Breast carcinoma
|
Disease state |
|
|
Lymph node
|
Organism part |
|
|
Mutant fumarate hydratase
|
Genotype |
|
|
Control
|
RNAi |
|
|
Primary
|
Disease staging |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Placebo
|
Compound treatment |
|
|
Macrophage
|
Cell type |
|
|
Not applicable
|
Histology |
|
|
Wild_type
|
Genotype |
|
|
N/a
|
Test result |
|
|
Mononuclear cell
|
Cell type |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Uninfected
|
Infection |
|
|
Control
|
Compound treatment |
|
|
Caudate nucleus
|
Organism part |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
White blood cells
|
Organism part |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Normospermic
|
Disease state |
|
|
Teratozoospermia
|
Disease state |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Malignant melanoma
|
Disease state |
|
|
Tumor
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
T47D
|
Cell line |
|
|
Grade IV
|
Tumor grading |
|
|
Wilms' tumor
|
Disease state |
|
|
Keratinocyte
|
Cell type |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
HaCaT
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
BT474
|
Cell line |
|
|
Grade II
|
Tumor grading |
|
|
Methotrexate
|
Compound treatment |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Gorilla gorilla
|
Organism |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Subthalamic nucleus
|
Organism part |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Baseline uninfected
|
Disease state |
|
|
SIM2s
|
RNAi |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Empty vector
|
Gene modification |
|
|
Testis
|
Organism part |
|
|
Astrocyte
|
Cell type |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Chondrocyte
|
Cell type |
|
|
T3aNxM1
|
Disease staging |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
U266
|
Cell line |
|
|
T3aN0Mx
|
Disease staging |
|
|
Epilepsy
|
Disease state |
|
|
Endothelial cell
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
Spermatid
|
Cell type |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
Primary fibroblast
|
Cell type |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Sporadic basal-like breast can...
|
Disease state |
|
|
Seminiferous tubule
|
Organism part |
|
|
Sevoflurane
|
Compound treatment |
|
|
Trigeminal ganglion
|
Organism part |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Spermatocyte
|
Cell type |
|
|
Oligodendroglioma
|
Disease state |
|
|
MiR15a/miR16-1 transfection
|
Gene modification |
|
|
Cartilage
|
Organism part |
|
|
Trichostatin A
|
Compound treatment |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Age-related macular degenerati...
|
Disease state |
|
|
Pan troglodytes
|
Organism |
|
|
BL41K3
|
Cell line |
|
|
BJABK3
|
Cell line |
|
|
Prostate
|
Organism part |
|
|
Smooth muscle
|
Organism part |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
CD3- CD4+ CD8-
|
Phenotype |
|
|
Intrathymic T progenitor cell
|
Cell type |
|
|
CD3high CD4+ CD8-
|
Phenotype |
|
|
Single positive thymocyte
|
Cell type |
|
|
Glutamine
|
Compound treatment |
|
|
Ciliary ganglion
|
Organism part |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
MCF-7
|
Cell line |
|
|
Atrioventricular node
|
Organism part |
|
|
Native skin
|
Cell type |
|
|
Kidney
|
Organism part |
|
|
Peripheral blood
|
Organism part |
|
|
Tonsil
|
Organism part |
|
|
Benign nevi
|
Disease state |
|
|
SKBR3
|
Cell line |
|
|
Enzo Labeling
|
Protocol type |
|
|
Grade III
|
Tumor grading |
|
|
Jurkat
|
Cell line |
|
|
Lung
|
Organism part |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
BT-474
|
Cell line |
|
|
Breast cancer
|
Disease state |
|
|
Cervical cancer
|
Disease state |
|
|
Spondyloarthropathy
|
Disease state |
|
|
KSHV latent infection
|
Disease state |
|
|
Capra hircus
|
Organism |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Heart
|
Organism part |
|
|
AsPC-1
|
Cell line |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
293
|
Cell line |
|
|
4 cm away from the tumor bound...
|
Observation |
|
|
Carboplatin resistant
|
Test result |
|
|
Carboplatin sensitive
|
Test result |
|
|
Permanent atrial fibrillation
|
Disease state |
|
|
No atrial fibrillation
|
Disease state |
|
|
ITM-E6E7
|
Cell line |
|
|
Whole blood
|
Organism part |
|
|
2 cm away from the tumor bound...
|
Observation |
|
|
Sapphyrin PCI-2051
|
Compound treatment |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Classic-KS, HIV-, nodular (lat...
|
Disease state |
|
|
None
|
Infection |
|
|
Treated malaria, natural infec...
|
Disease state |
|
|
Secretory cell
|
Cell type |
|
|
Uterine fibroid
|
Disease state |
|
|
Control
|
Genotype |
|
|
Sulmazole
|
Compound treatment |
|
|
Thymus
|
Organism part |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Total_RNA
|
Material type |
|
|
Polysome-associated RNA
|
Material type |
|
|
Monocyte
|
Cell type |
|
|
GFP transfected
|
Genotype |
|
|
RUNX1-RUNX1T1 transfected
|
Genotype |
|
|
Primary bone marrow CD34+ stem...
|
Cell type |
|
|
GLI60
|
Cell line |
|
|
Dendritic cell
|
Cell type |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
Skin substitute
|
Cell type |
|
|
PEL-5
|
Cell line |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Vulvar intraepithelial neoplas...
|
Disease state |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
Normal donor
|
Clinical info |
|
|
Rheumatoid arthritis
|
Disease state |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
LEDGF knockdown
|
RNAi |
|
|
Primary gastric tumor
|
Organism part |
|
|
Fetal thyroid
|
Organism part |
|
|
G3
|
Tumor grading |
|
|
Leydig cell
|
Cell type |
|
|
Baseline sevoflurane
|
Compound treatment |
|
|
SsMCF7
|
Cell line |
|
|
Fetal lung
|
Organism part |
|
|
Normal
|
Histology |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Vasectomized
|
Clinical history |
|
|
Rapamycin
|
Compound treatment |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
B-precursor acute lymphoblasti...
|
Disease state |
|
|
17-allylamino-geldanamycin
|
Compound treatment |
|
|
NCI-H929
|
Cell line |
|
|
DMSO
|
Vehicle |
|
|
HTERT/HPVE6 transfection
|
Gene modification |
|
|
RelA knockdown
|
RNAi |
|
|
M1 macrophage
|
Cell type |
|
|
CD14+ monocyte
|
Cell type |
|
|
Unsynchronized
|
Growth condition |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Beta cell islets
|
Organism part |
|
|
Symptomatic
|
Disease staging |
|
|
Acute myeloid leukemia
|
Disease state |
|
|
Pancreatic cancer
|
Disease state |
|
|
Down syndrome
|
Disease state |
|
|
Retinoic acid
|
Compound treatment |
|
|
Media only
|
Growth condition |
|
|
Astrocytic tumor
|
Disease state |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
Gastric cancer
|
Disease state |
|
|
Granulocyte
|
Cell type |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Multiple myeloma
|
Disease state |
|
|
Well-functioning transplant
|
Clinical info |
|
|
Baseline propofol
|
Compound treatment |
|
|
Oligodendroglioma with 1p19q c...
|
Disease state |
|
|
Constantinidis type A
|
Disease staging |
|
|
Lymphoid tissue
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Neuroblastoma
|
Disease state |
|
|
Ewing family tumor
|
Disease state |
|
|
Ovary
|
Organism part |
|
|
Basal cell
|
Cell type |
|
|
Inferior parietal lobule
|
Organism part |
|
|
Stage III/3
|
Disease staging |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Cerebellum peduncles
|
Organism part |
|
|
COPD; GOLD-II, 60-pack years
|
Clinical info |
|
|
Lymph node metastasis
|
Disease staging |
|
|
SKMEL5
|
Cell line |
|
|
None
|
Gene modification |
|
|
Fetal brain
|
Organism part |
|
|
IgV status unknown
|
Genotype |
|
|
Constantinidis type C1
|
Disease staging |
|
|
Unknown_sex
|
Sex |
|
|
WE 68
|
Cell line |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
HTERT transfection
|
Gene modification |
|
|
Valproic acid
|
Compound treatment |
|